Rhinovirus Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2018-05-07
Clinical Trial Update: A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection [Phase 2]
The Phase 2 trial of vapendavir for rhinovirus infection in hematopoietic stem cell transplant patients has been withdrawn.